Portman Square Capital’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.8M Sell
354,200
-14,000
-4% -$2.47M 2.27% 14
2026
Q1
$66.1M Sell
368,200
-185,300
-33% -$31.6M 2.55% 12
2025
Q4
$78.3M Buy
553,500
+297,500
+116% +$33.8M 3.46% 7
2025
Q3
$20.8M Sell
256,000
-324,000
-56% -$25M 0.92% 31
2025
Q2
$36.3M Buy
580,000
+48,800
+9% +$2.89M 1.06% 27
2025
Q1
$38.3M Buy
+531,200
New +$43.2M 1.02% 24

Other funds holding ALB

Portman Square Capital's ALB Position: Q2 2026 in Review

Portman Square Capital reduced its Albemarle (ALB) stake by 74% in Q2 2026, selling an estimated $11.3M and leaving 22,642 shares worth $3.06M. The position accounts for 0.14% of the portfolio, ranked #75.

Portman Square Capital first reported a position in ALB in Q3 2025 and has held it in 4 quarters since. The position peaked at $15.6M in Q1 2026. 151 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Portman Square Capital held 22,642 shares of Albemarle worth $3.06M as of Q2 2026.
  • Portman Square Capital sold 64,169 Albemarle shares in Q2 2026, an estimated $11.3M.
  • Albemarle made up 0.14% of Portman Square Capital's portfolio in Q2 2026, its #75 holding.
  • Portman Square Capital first reported a position in Albemarle in Q3 2025 and has held it in 4 quarters since.
  • Portman Square Capital's Albemarle position peaked at $15.6M in Q1 2026.
  • 151 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Portman Square Capital's 13F filing for Q2 2026, filed 15 Jul 2026.